Several factors are associated with overall and progression-free survival in patients with limited-stage small cell lung cancer receiving chemoradiotherapy, according to researchers.

Researchers sought to better understand the experiences of patients living with multiple myeloma and their perceptions of palliative care.

The investigational drug BMS-986365 may help patients with mCRPC previously treated with ARPIs overcome drug resistance, despite their genomic status. The investigational dual androgen receptor ...